DMSO Dual-Route Therapy for Refractory Tinnitus in Long-COVID and Post-COVID-19 Vaccine Injury

Name: DMSO Dual-Route Therapy for Refractory Tinnitus in Long-COVID and Post-COVID-19 Vaccine Injury
License: Public Domain

Leading Edge Clinic

ClinicalTrials.gov · Datasets · License: Public Domain

tinnitus

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 272400
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.